Home/ Supplements/ Electrolytes/ FerraPlus 90 Tablets

FerraPlus 90 Tablets

product on market Tablet or Pill Trigen Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Iron, folic acid, and vitamin B12 are supported by strong evidence for treating and preventing anemia. Vitamin C is included to enhance iron absorption, while docusate sodium serves as a stool softener. Overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for FerraPlus 90 Tablets
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
90
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg (15% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
1 mg (250% DV)
2.5× RDA — within safe limits 226 studies (A:10, B:105)
Iron
90 mg (15% DV)
12 mcg (15% DV)
5.0× RDA — above typical dose 139 studies (A:1, B:44)
Vitamin C
120 mg (15% DV)

Other Ingredients

Microcrystalline Cellulose Di Calcium Phosphate Tripotassium Citrate Sodium Carboxymethyl Cellulose Acacia Povidone K30 Croscarmellose Sodium fumed Silica Stearic Acid Magnesium Stearate Citric Acid Dextrin Dextrose Lecithin Sodium Citrate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use One tablet daily or as directed by a physician. Do not chew tablet.

Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of fetal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).

Keep out of the reach of children.

Formulation Notes

With 90 mg carbonyl iron

Additional Information

Storage Store at 20(0)-25(0)C (68(0)-77(0)F, excursions permitted to 15(0)-30(0)C (59(0)-86(0)F) [See USP controlled room temperature].

Description FerraPlus90 is a dark grey, oval, film-coated tablet, debassed "TL012".

Indications And Usage FerraPlus 90 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These Include: Hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.

Each Dark Grey Film-Coated Tablet For Oral Administration Contains:

Rev. 07/13

13811-012-90 Rx only

Metadata

Product Details

UPC / SKU3 13811 01290 3
DSLD Entry Date2018-02-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID82219
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.